Navigation Links
Statement by Ronald L. Stotish, Ph.D., President and CEO of AquaBounty Technologies
Date:6/16/2011

WALTHAM, Mass., June 16, 2011 /PRNewswire-USNewswire/ -- Background: The U.S. House of Representatives yesterday passed an amendment to H.R. 2112, the House agricultural appropriations bill, co-sponsored by Rep. Don Young (R-AK) and Rep. Lynn Woolsey (D-CA) to prohibit funding for U.S. Food and Drug Administration approval of salmon grown from AquaBounty Technologie's AquAdvantage salmon eggs.  The amendment was voted on by fewer than ten of the total 435 House members.

The U.S. FDA has conducted a rigorous 15-year review of thousands of pages of data and has concluded that these fish are exactly the same as any other Atlantic salmon and, therefore, are safe for consumption.  In addition, the fish will be sterile and required to be grown in self-contained inland tanks, so pose no threat to the environment.  Finally, the United Nations reports that the wild caught fisheries are severely stressed, with  major food species potentially extinct by 2050, yet the demand for fish protein is exploding worldwide. America currently imports more than 97% of the Atlantic salmon consumed here, so Young et al are really supporting foreign salmon producers.

Statement:

"This outrageous action is wrong on the facts, wrong on the process and wrong on the policy.  A handful of representatives have chosen to subvert the FDA's rigorous 15-year plus process. It completely ignores the results of a rigorous scientific review. This sort of political gamesmanship undermines the science-based system that protects the nation's health and safety. It is astonishing that Young and a few colleagues would try to game the system in this way."

"Whether or not you support this transgenic salmon, we should all agree these types of shenanigans have no place in a complex scientific debate.  These actions threaten the fundamental basis of a science-based regulatory process. Americans deserve better from their elected representatives."


'/>"/>
SOURCE AquaBounty Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Resverlogix Issues a Management Statement
2. Extraordinary General Meetings Statement - XTL Notifies NASDAQ of Compliance with Marketplace Rule 4350(d)(2)
3. Helix BioPharma Files Form 20-F Registration Statement With the U.S. Securities and Exchange Commission
4. Sinovac Releases Statement on Healive Vaccine Suspension
5. CV Therapeutics Statement on Unsolicited Proposal From Astellas
6. GPhA Statement on the Introduction of the Bipartisan Biogenerics Consensus Bill: Promoting Innovation and Access to Life-Saving Medicine Act
7. Helix BioPharma Form 20-F Registration Statement Declared Effective by SEC
8. Extraordinary General Meetings Statement -- XTL Also Announces Board and Management Changes
9. Advanced Life Sciences Announces Filing of Shelf Registration Statement
10. Amylin Issues Statement in Response to Carl Icahn
11. DuPont Statement on Obama Administration Biofuels Interagency Working Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... Connecticut (PRWEB) , ... May 25, 2016 , ... ... the U.S. Food and Drug Administration (FDA) has granted the company’s orphan drug ... the company’s second orphan drug designation granted by the FDA. , Spinocerebellar ...
(Date:5/23/2016)... ... ... blood donations in South Texas and across the nation is growing. , But according to ... are on the decline. In fact, donations across the country are at their lowest point ... the last four years alone. , There is no substitute for blood. , “We want ...
(Date:5/23/2016)... ... May 23, 2016 , ... RoviSys, a ... based in Aurora, Ohio, has broken ground on a new building in Holly ... Park area, this new location solidifies a commitment to business in the region. ...
(Date:5/20/2016)... ... 2016 , ... Korean researchers say Manumycin A triggers apoptosis, or natural cell ... treat the disease. Surviving Mesothelioma has just posted an article on the new study. ... based their mesothelioma study on the fact the Manumycin A, a derivative of Streptomyces ...
Breaking Biology Technology:
(Date:3/14/2016)... , March 14, 2016 NXTD ... growing mobile commerce market, announces the airing of a new ... starting the week of March 21 st .  The commercials ... including its popular Squawk on the Street show. --> ... on the growing mobile commerce market, announces the airing of ...
(Date:3/11/2016)... -- --> --> ... Market by Technology (Pattern Recognition), by Component (Hardware, Software, ... (On-Premises and Cloud), by Industry Vertical and by Region ... global market is expected to grow from USD 12.49 ... at a CAGR of 19.1%. , ...
(Date:3/9/2016)... This BCC Research report provides an overview ... Sequencing (RNA Seq) market for the years 2015, 2016 ... reagents, data analysis, and services. Use this ... market such as RNA-Sequencing tools and reagents, RNA-Sequencing data ... each segment and forecast their market growth, future trends ...
Breaking Biology News(10 mins):